EMR
May 7, 2025 - AI Summary
Overvalued by 55.5% based on the discounted cash flow analysis.
Market cap | $67.15 Billion |
---|---|
Enterprise Value | $81.38 Billion |
Dividend Yield | $2.1075 (1.76537108393366%) |
Earnings per Share | $3.44 |
Beta | 1.25 |
Outstanding Shares | 563,000,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 28.06 |
---|---|
PEG | -878.72 |
Price to Sales | 3.85 |
Price to Book Ratio | 3.51 |
Enterprise Value to Revenue | 4.62 |
Enterprise Value to EBIT | 32.45 |
Enterprise Value to Net Income | 33 |
Total Debt to Enterprise | 0.2 |
Debt to Equity | 0.84 |
No data
No data